i-spero® News

i-spero® brings together decades of clinical research and proven artificial intelligence to deliver digital tools that improve recovery rates for patients whilst reducing the overall cost of treatment.

First walk in clinic using i-spero® will open in Faversham on 4 July 2019!

i‑spero® will be used as a part of Low mood, depression and anxiety walk in clinic in Faversham.

0 minutes
First walk in clinic using i-spero® will open in Faversham on 4 July 2019!

Funding awarded to P1vital Products will help transform treatment of depression using digital technology.

P1vital Products (PPL) has, in partnership with Canterbury and Coastal CCG, University of Kent, and the mental health charity MIND, been awarded £815,506 by the UK’s innovation agency, Innovate UK, to advance research to improve the treatment of depression.

3 minutes
Funding awarded to P1vital Products will help transform treatment of depression using digital technology.

European Neuropsychopharmacology article talks about predicting treatment response

New article on predicting antidepressant treatment response was published in November issue of European Neuropsychopharmacology

1 minute
European Neuropsychopharmacology article talks about predicting treatment response

Innovate UK Award

We are pleased to announce that P1vital Products Ltd was awarded Innovate UK Grant.

1 minute
Innovate UK Award
1